CYP39A1 polymorphism is associated with toxicity during intensive induction chemotherapy in patients with advanced head and neck cancer

BACKGROUND: Induction chemotherapy incorporating docetaxel, cisplatin and 5- fluorouracil before radiotherapy may improve the outcome of patients with advanced head and neck cancer. Nevertheless, the addition of docetaxel increases hematological toxicity and infectious complications. Therefore, gene...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Cancer
Main Authors: Melchardt, Thomas, Hufnagl, Clemens, Magnes, Teresa, Weiss, Lukas, Hutarew, Georg, Neureiter, Daniel, Schlattau, Alexander, Moser, Gerhard, Gaggl, Alexander, Tränkenschuh, Wolfgang, Greil, Richard, Egle, Alexander
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2015
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4609094/
https://ncbi.nlm.nih.gov/pubmed/26475344
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-015-1776-x
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados